Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LIPG |
| Upstream (Parents) |
|---|
| (<<) ACAT2 → LIPG |
| (<<) AQP3 → LIPG |
| (<<) CSNK1E → LIPG |
| (<<) DUSP1 → LIPG |
| (<<) DUSP10 → LIPG |
| (<<) HSD17B2 → LIPG |
| (<<) KHDRBS1 → LIPG |
| (<<) PNPLA3 → LIPG |
| (<<) PRKAB1 → LIPG |
| (<<) PYGL → LIPG |
| (<<) SLPI → LIPG |
| (<<) SULT1A2 → LIPG |
| Downstream (Children) |
|---|
| LIPG → ADAM19 (>>) |
| LIPG → CCND2 (>>) |
| LIPG → COX6A2 (>>) |
| LIPG → DHCR7 (>>) |
| LIPG → GPRIN2 (>>) |
| LIPG → HMGCS1 (>>) |
| LIPG → JHDM1D (>>) |
| LIPG → MMP3 (>>) |
| LIPG → MTMR6 (>>) |
| LIPG → NAB2 (>>) |
| LIPG → NDOR1 (>>) |
| LIPG → PFDN1 (>>) |
| LIPG → UST (>>) |
| LIPG → WNT3 (>>) |
